Thymosin Alpha-1 Dosage Guide

What Is Thymosin Alpha-1 and Why Does Dosing Matter?

Thymosin Alpha-1 (Thymosin alpha 1 (28-amino acid peptide)) is a Thymic peptide, immunomodulator. Naturally occurring peptide isolated from thymus gland; synthetic form (thymalfasin/Zadaxin) developed for immune enhancement. Getting the dosage right is critical — too little may produce no measurable effect, while excessive amounts increase risk without proportional benefit.

The standard research dosage for Thymosin Alpha-1 has been established through preclinical studies and community protocols. This guide covers the evidence-backed dosing range, timing, and cycle structure.

What Is the Recommended Thymosin Alpha-1 Dosage?

The most widely used Thymosin Alpha-1 dosage is 1.6-6.4 mg per dose, administered twice weekly via subcutaneous injection.

Beginners should start at the lower end of this range and titrate upward only if needed. The half-life of Thymosin Alpha-1 is not established, which directly determines how often you need to dose to maintain stable blood levels.

For Thymosin Alpha-1 specifically, the 5-7 day injection cycles, repeated as needed cycle length is standard. Longer isn't always better — Thymic peptide, immunomodulator compounds require cycling to maintain receptor sensitivity.

When Should You Dose Thymosin Alpha-1?

With a half-life of not established, timing your Thymosin Alpha-1 administration affects peak blood levels. Most protocols call for twice weekly.

For peptides administered before bed (common with GH-related compounds), the goal is to amplify the natural nocturnal growth hormone pulse. For healing peptides, proximity to the injury site via local injection can improve outcomes.

How Do You Reconstitute Thymosin Alpha-1?

Thymosin Alpha-1 typically comes as a lyophilized (freeze-dried) powder. Reconstitute with bacteriostatic water — never saline or sterile water, as BAC water contains 0.9% benzyl alcohol that prevents bacterial growth and extends shelf life to 4-6 weeks.

Use our peptide dosing calculator to determine the exact amount of BAC water to add based on your vial size and desired dose per injection.

How Long Should a Thymosin Alpha-1 Cycle Last?

Standard Thymosin Alpha-1 cycles run 5-7 day injection cycles, repeated as needed. This timeframe is based on the compound's mechanism and the time needed to observe measurable effects.

FDA-approved as orphan drug for melanoma, DiGeorge syndrome, chronic hepatitis B, and hepatocellular carcinoma. Clinical trials ongoing for lung cancer, hepatitis C, HIV, and COVID-19. Approved in 35 countries.

What Side Effects Can Affect Dosing?

Well-tolerated. Local injection site reactions most common. Safe in liver disease, cancer, and autoimmune conditions. No significant organ toxicity.

If side effects emerge, the first step is typically reducing the dose rather than discontinuing entirely. Most Thymosin Alpha-1-related side effects are dose-dependent.

How Does Thymosin Alpha-1 Dosing Change When Stacking?

Synergizes with interferons and antivirals for enhanced immune priming. Off-label stacking with checkpoint inhibitors in cancer immunotherapy.

When stacking, some researchers reduce individual peptide doses by 20-30% since synergistic effects mean full doses of each aren't always necessary.

What Is the Bottom Line on Thymosin Alpha-1 Dosing?

Start at 1.6, dose twice weekly, and run cycles of 5-7 day injection cycles, repeated as needed. Monitor your response and adjust within the established range.

Source matters — always use research-grade Thymosin Alpha-1 from vendors with third-party COA testing. Underdosed or contaminated products are the most common reason for poor results.

Related Reading

• Thymosin Alpha-1 Benefits
• Thymosin Alpha-1 Side Effects
• Thymosin Alpha-1 Stacking Guide
• Thymosin Alpha-1 Cycle Guide
• Thymosin Alpha-1 Research
• AOD-9604 Complete Guide

Frequently Asked Questions